Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D. C. 20549 FORM 10 - Q X Quarterly Report Pursuant to Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 For the quarterly period ended : March 31 , 2021 or Transition Report Pursuant to Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 For the transition period from_ Nevada ( State or other jurisdiction of incorporation or organization ) to Commission file number : 0-25466 CYCLO THERAPEUTICS , INC . ( Exact name of registrant as specified in its charter ) 6714 NW 16th Street , Suite B , Gainesville , Florida ( Address of principal executive offices ) Securities registered pursuant to Section 12 ( b ) of the Act : Title of each class Common Stock , par value $ .0001 per share Warrants to purchase Common Stock Registrant's telephone number , including area code : 386-418-8060 Trading Symbol ( s ) 59-3029743 ( IRS Employer Identification No. ) 32653 ( Zip Code ) CYTH CYTHW Securities registered pursuant to Section 12 ( g ) of the Act : None Name of each exchange on which registered The Nasdaq Stock Market LLC The Nasdaq Stock Market LLC Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes ☐ No X Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes ☐ No X Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . X Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( §232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . X Yes No Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company , or an emerging growth company . See definitions of " large accelerated filer , " " accelerated filer , " " smaller reporting company , " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . Large accelerated filer Non - accelerated filer ☐ ☑ Accelerated filer Smaller reporting company Emerging growth company X If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . ☐ Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Exchange Act ) As of May 3 , 2021 the Company had outstanding 6,358,661 shares of its common stock . Yes X No